These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Katie Cottingham reports from the American Association for Cancer Research 96th Annual Meeting--Anaheim, Calif. Have biomarkers, will validate. Cottingham K J Proteome Res; 2005; 4(3):665. PubMed ID: 15984100 [No Abstract] [Full Text] [Related]
27. SERS Nanoparticles in Medicine: From Label-Free Detection to Spectroscopic Tagging. Lane LA; Qian X; Nie S Chem Rev; 2015 Oct; 115(19):10489-529. PubMed ID: 26313254 [No Abstract] [Full Text] [Related]
28. Molecular Markers in the Diagnosis and Treatment of Cancer. Gokden M; Ariza A; Arnaoutakis K Biomed Res Int; 2015; 2015():105217. PubMed ID: 26451364 [No Abstract] [Full Text] [Related]
29. Interference by human antibodies with tumor marker assays. Reinsberg J Hybridoma; 1995 Apr; 14(2):205-8. PubMed ID: 7590781 [TBL] [Abstract][Full Text] [Related]
30. Cancer biomarker testing in the everyday practice of pathology. Cagle PT; Stein K; Oommen J; Shemon M; Kyle W Arch Pathol Lab Med; 2015 May; 139(5):583-4. PubMed ID: 25927145 [No Abstract] [Full Text] [Related]
31. Tumour markers in the years to come; challenges, possibilities and goals. Vockel A Scand J Clin Lab Invest Suppl; 1991; 206():102-5. PubMed ID: 1947755 [No Abstract] [Full Text] [Related]
32. Rules of evidence for cancer molecular-marker discovery and validation. Ransohoff DF Nat Rev Cancer; 2004 Apr; 4(4):309-14. PubMed ID: 15057290 [No Abstract] [Full Text] [Related]
33. CD44 as a potential diagnostic tumor marker. Basakran NS Saudi Med J; 2015 Mar; 36(3):273-9. PubMed ID: 25737167 [TBL] [Abstract][Full Text] [Related]
34. New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use. Becker TM; Caixeiro NJ; Lim SH; Tognela A; Kienzle N; Scott KF; Spring KJ; de Souza P Int J Cancer; 2014 Jun; 134(11):2523-33. PubMed ID: 24122526 [TBL] [Abstract][Full Text] [Related]
35. [Updates on molecular markers of prostatic cancer]. Chang B; Li F; Song LJ Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):339-41. PubMed ID: 18956656 [No Abstract] [Full Text] [Related]
36. Tumoral markers in tumors of the pineal region. Faure-Conter C Neurochirurgie; 2015; 61(2-3):143-5. PubMed ID: 24856314 [TBL] [Abstract][Full Text] [Related]
38. Molecular Biomarkers of Disease for Diagnosis and Drug Development. Berisio R Curr Med Chem; 2019; 26(11):1922-1923. PubMed ID: 31293226 [No Abstract] [Full Text] [Related]
39. Cancer dynamics and the success of cancer screening programs. Diamandis EP Clin Chem Lab Med; 2016 Aug; 54(8):e211-2. PubMed ID: 26751900 [No Abstract] [Full Text] [Related]
40. CD44 and Helicobacter pylori-related colon oncogenesis. Kountouras J; Kapetanakis N Saudi Med J; 2015 Oct; 36(10):1249. PubMed ID: 26446341 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]